Wu, Yudan
Jin, Tianyu
Pang, Qiongyi
Cheng, Yifan
Funding for this research was provided by:
Wenzhou Science and Technology Bureau Public Welfare Technology Research Medical Project (Y20190005)
Medical Science and Technology Project of Zhejiang Province (2022KY506 and 2024KY025)
Article History
Received: 20 September 2024
Accepted: 21 November 2024
First Online: 30 November 2024
Declarations
:
: Each participant received ethical approval and informed consent for the respective study. This study used publicly available GWAS data. For serum 25(OH)D levels, the data was obtained from the UK Biobank under the generic approval of the NHS National Research Ethics Service (projects 12505 and 10214). For the functional outcome of ischemic stroke, all participants provided written informed consent, and for those unable to communicate, consent was obtained from their next of kin. Local ethics committees approved the original studies, which ensured that ethical approvals and participant consents were in place. All data were complied with relevant data-sharing policies. Consequently, no additional ethical approval was required for this secondary analysis.
: No conflict of interest exists in the submission of this manuscript, and the manuscript is approved by all authors for publication.
: The authors declare no competing interests.